Bain Capital Public Equity Management’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Bain Capital Public Equity Management’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-228,517	Closed	-$12.2M	–	79
2017 Q1	$12.2M	Sell	228,517 -99,596	-30%	-$5.91M	0.86%	33
2016 Q4	$16.4M	Sell	328,113 -39,201	-11%	-$2.1M	1.11%	31
2016 Q3	$22.1M	Sell	367,314 -56,800	-13%	-$3.27M	1.43%	22
2016 Q2	$21.7M	Hold	424,114	–	–	0.91%	27
2016 Q1	$12.5M	Sell	424,114 -3,982	-0.9%	-$126K	0.47%	30
2015 Q4	$19.4M	Hold	428,096	–	–	0.56%	32
2015 Q3	$17.9M	Hold	428,096	–	–	0.53%	35
2015 Q2	$25.8M	Hold	428,096	–	–	0.67%	33
2015 Q1	$33.2M	Buy	+428,096	New	+$24.7M	0.82%	35

Other funds holding ONCE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bain Capital Public Equity Management's ONCE Position: Q2 2017 in Review

Bain Capital Public Equity Management sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q2 2017, closing a stake of 228,517 shares — an estimated $12.2M sold.

Bain Capital Public Equity Management first reported a position in ONCE in Q1 2015 and held it in 9 quarters. The position peaked at $33.2M in Q1 2015. 127 funds tracked by Wall St. Rank hold ONCE as of Q2 2017.

Bain Capital Public Equity Management reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
Bain Capital Public Equity Management sold 228,517 Spark Therapeutics, Inc. Common Stock shares in Q2 2017, an estimated $12.2M.
Bain Capital Public Equity Management first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2015 and held it in 9 quarters.
Bain Capital Public Equity Management's Spark Therapeutics, Inc. Common Stock position peaked at $33.2M in Q1 2015.
127 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q2 2017.

Based on Bain Capital Public Equity Management's 13F filing for Q2 2017, filed 14 Aug 2017.